NTRK1 and melanoma: Further in vitro and in vivo studies found that AR increased MITF protein degradation by modulating miRNA‐539‐3p/USP13 signalling, which resulted in increased melanoma cell invasion by increasing the expression of the receptor tyrosine kinase AXL.19